Clinical trials: Dementia Frontal

Amyotrophic Lateral Sclerosis, Frontal Temporal Dementia

Therapy in Amyotrophic Lateral Sclerosis (TAME)

• Completed
• Age: 18 to 85 years
• Phase 2
• Results posted

The purpose of this study is to determine if memantine at up to 20 mg twice a day when used in conjunction with riluzole, can slow down the disease progression of patients with ALS including potentially improving their…

Trial name

TAME (NCT02118727)

Testing

Memantine

Where

13 sites in United States

Volunteers

89 people

Sponsor

University of Kansas Medical Center